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ABSTRACT: Comparative assessment of methanolic extracts of Spondias mombin leaves and Curcuma longa 
rhizomes on Blood Glucose and Glycosylated Haemoglobin using male wistar rats as models was attempted.  90 rats divided 
into 9 groups of 10 rats each were used. Groups: 1: Untreated non diabetic; 2: Untreated diabetic; 3: diabetic + low dose 
(200mg/kg/b.w) Spondias mombin; 4: diabetic + high dose (400mg/kg/b.w) Spondias mombin; 5: diabetic + low dose 
(500mg/kg/b.w) Curcuma longa; 6: diabetic + high dose (1000mg/kg/b.w) Curcuma longa; 7: diabetic + low dose combined 
(200mg/kg/b.w) Spondias mombin and (500mg/kg/b.w) Curcuma longa; 8: diabetic + high dose combined (400mg/kg/b.w) 
Spondias mombin and (1000mg/kg/b.w) Curcuma longa; and diabetic + (0.6mg/kg/b.w) glibenclamide. Diabetes was 
induced intraperitonially using alloxan at 200mg/kg. Treatments with extracts were orally and for 42days. Blood was 
collected on day 43 by cardiac puncture for determination of blood glucose and glycosylated haemoglobin. A significant 
decrease in blood glucose and glycosylated haemoglobin concentrations was observed in all the treated groups compared 
to group 2 (p< 0.05). Groups 7 and 8 rats showed a significant reduction in blood glucose and glycosylated haemoglobin 
compared to groups 3 to 6 (p< 0.05). Spondias mombin apparently showed better anti-diabetic effects compared to Curcuma 
longa as seen amongst Groups 3 and 4 rats compared to Groups 5 and 6 rats. Result suggest that combined treatment with 
Spondias mombin and Curcuma longa may possess better anti-diabetic effects compared to administration of each singly. 
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On account of poor dietary habits, a sedentary life style 
and increasing worldwide prevalence of obesity, 
diabetes mellitus is rapidly emerging as a global health 
challenge threatening to reach pandemic proportion by 
2030 (WHO, 2008). In developing countries, the 
increased incidence of diabetes has been ascribed to 
dietary and lifestyle changes with the associated shift 
from the relatively healthy traditional lifestyle to an 
unhealthy lifestyle (Godfrey and Julien, 2005). 
Epidemiologists predict that 70% of Africans will live 
in cities by 2025; invariably increasing the number of 
Africans at risk for diabetes (IDF, 2014). In 2014, the 
worldwide prevalence of diabetes was estimated at 
8.3% (approximately 382 million adults) with an 
estimated 46% of undiagnosed; projected to increase 
to 53% (approximately 592 million adults) by 2035 
(IDF, 2014). Predictably, this poses an economic 
burden on developing countries currently estimated at 
over USD 372 billion per annum (Oguejiofor et al., 
2014). 
Management of diabetes with minimal side effects is 
still a challenge to the medical profession. Commonly 
used synthetic anti-diabetic agents could produce side 
effects such as hypoglycemic coma and hepatorenal 
disturbances and are generally not indicated in 
pregnancy (Gupta et al., 2007; Atta-Ur-Rahman and 
Zaman, 1989). Therefore, the search for safer and 
perhaps more effective anti-diabetic agents is an 
ongoing challenge. It is estimated that 80% of the 
world's populations rely upon plants for their health 
needs (Abo et al., 2008; Li et al., 2004). Spondias 
mombin Linn (Anarcadiaceae) commonly known as 
‘hog plum,’ is a deciduous tree with large panicles of 
small white flowers and yellow plum-like fruits (Gbile 
and Soladoye, 2002). It is common in farmlands and 
villages especially in the forest and savannah regions. 
In traditional folklore medicine, Spondias mombin 
leaves are used as an emetic and for treatment of 
gonorrhoea, diabetes and psychiatric disorders; 
(Oliver-Bever, 1960) it is also useful for the expulsion 
of the placenta in goats;(Oliver-Bever, 1960) as an 
astringent; (Oliver-Bever, 1960; Abo et al., 1999) an 
oxytocic agent; (Ayensu, 1978) and in wound 
treatment (Oliver-Bever, 1960). Curcuma longa 
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(Linn) commonly known as turmeric is an erect 
perennial herb with pulpy orange tuberous roots that 
grows to about 2 feet in length (Gopinathan et al., 
2011; Sawant and Godghate, 2013). It belongs to the 
family Zingiberaceae. Its rhizome is pungent with a 
bitter taste and widely used in indigenous medicine as 
a general household remedy and a cooking spice 
(Gopinathan et al., 2011; Aggarwal et al., 2005). It has 
been reported beneficial for the treatment of diabetes, 
high cholesterol, abdominal pains, menstrual 
disorders, wounds, eczema, jaundice, inflammation, 
cancer symptoms and as a blood purifying agent 
(Sawant and Godghate, 2013). The herb contains 
curcumin as an active ingredient, which is a yellow 
colored phenolic pigment obtained from the powdered 
rhizome. Reports on the anecdotal use of both plants 
singly or in combination as potential treatment of 
diabetes have recently become widespread in our 
environment. These anecdotal reports have been fairly 
validated by a recent report describing the possible 
anti-diabetic activity of the aqueous extract of 
Curcuma longa rhizomes in alloxan induced diabetic 
rats (Olatunde et al., 2014). The present study 
therefore, presents a preliminary report of a 
comparative assessment of the anti-diabetic effects of 
methanolic extracts of Spondias mombin leaves and 
Curcuma longa rhizomes in alloxan-induced diabetes 
using male wistar rats as models. This is with the aim 
of validating and further determining the anti-diabetic 
potentials of the methanolic extract of each plant either 
singly or in combination. 
 
MATERIALS AND METHODS 
Plant materials and extract preparation: Fresh leaves 
of Spondias mombin were obtained from the 
University of Port Harcourt botanical garden; while 
Curcuma longa rhizomes were obtained from a local 
market in Rivers state, Nigeria. Both plant specimens 
were identified and authenticated by Dr. C. Ekeke of 
the Department of Plant Science and Biotechnology, 
University of Port Harcourt, Nigeria. Voucher 
specimens of both plants were deposited in the 
herbarium. The research protocol for the study was 
approved by the Ethics Committee of our institution 
vides a communication referenced: 
UPH/R&D/REC/04 and dated 3rd July, 2018. This 
study was conducted in accordance with the guidelines 
for the care and use of laboratory animals issued by the 
United States Institute for Laboratory and Animal 
Research (1996). 
 
Leaves of Spondias mombin were dried at room 
temperature for a minimum of 14 days and extracted 
using the percolation method as described by Fred-
Jaiyesimi and Abo, 2009. Briefly, the Spondias 
mombin leaves were grounded into powder; 
subsequently, 8.8kg was properly macerated with 98% 
methanol for three days and the percentage yield was 
93%. It was then filtered and concentrated using rotary 
evaporator at 40°C. The obtained extract was kept in 
air tight containers and stored at room temperature 
before use. Rhizomes of Curcuma longa were oven 
dried at 40°C for 72 hours to a constant weight. The 
dried rhizomes were then pulverized using a 
household blender. 7.5g of the powder obtained was 
dissolved in 98% methanol for about two days and the 
percentage yield was 96%. The extraction procedure 
employed was percolation as described by Olatunde 
et. al., 2014. 
 
Experimental animals and drugs: 90 male wistar rats 
weighing between 120-250g were used for this study. 
The animals were kept at the Animal House, 
Department of Physiology, Faculty of Basic Medical 
Sciences, University of Port Harcourt, Nigeria. The 
rats were fed with normal rat pellet and tap water ad 
libitum. The experimental animals were acclimatised 
for a period of two weeks after which they were 
properly grouped. Alloxan monohydrate was obtained 
from Sigma-Aldrich Co., 3050 Spruce Street, St. 
Louis, USA. While glibenclamide was obtained from 
Swiss Pharm Nigeria Ltd, 5, Dopemu Road, Agege, 
Lagos, Nigeria. 
 
Acute toxicity study (LD50): The LD50 value of the leaf 
extract of Spondias mombin was assumed to be greater 
than 1000mg/kg bw as reported by Olatunde et. al., 
(2014). Similarly, the LD50 value of the methanol 
extract of Curcuma longa rhizomes was regarded as 
the value obtained by Yuandani, (2017) which was 
reported to be greater than 5000mg/kg bw. 
 
Experimental design: The rats were subsequently 
randomly divided into 9 groups of 10 each. Diabetes 
was induced in all rat groups except Group 1 using 
alloxan at a dose of 200mg/kg bw administered 
intraperitonially. Diabetes was confirmed after 72 
hours of alloxan administration if the blood glucose is 
≥ 11.1 mmol/L (200mg/dl) (Stanley Mainzen Prince 
and Menon, 2001). Each rat group was subsequently 
treated as follows: 
Group 1: untreated non-diabetic; rats in this group had 
free access to only normal rat chow and tap water ad 
libitum. 
Group 2: untreated diabetic; rats in this group received 
no further treatment after induction of diabetes. 
Group 3: diabetic + low dose Spondias mombin; rats 
in this group were treated with 200mg/kg bw of 
Spondias mombin extract daily after the induction of 
diabetes. 
Group 4: diabetic + high dose Spondias mombin; rats 
in this group were treated with 400mg/kg bw of 
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Spondias mombin extract daily after the induction of 
diabetes. 
Group 5: diabetic + low dose Curcuma longa; rats in 
this group were treated with 500mg/kg bw Curcuma 
longa extract daily after the induction of diabetes. 
Group 6: diabetic + high dose Curcuma longa; rats in 
this group were treated with 1000mg/kg bw Curcuma 
longa extract daily after the induction of diabetes. 
Group 7: diabetic + combined low doses of Spondias 
mombin and Curcuma longa; rats in this group were 
treated with both 200mg/kg bw of Spondias mombin 
and 500mg/kg bw of Curcuma longa extracts daily 
after the induction of diabetes. 
Group 8: diabetic + combined high doses of Spondias 
mombin and Curcuma longa; rats in this group were 
treated with both 400mg/kg/bw of Spondias mombin 
and 1000mg/kg bw of Curcuma longa extracts daily 
after the induction of diabetes. 
Group 9: diabetic + glibenclamide; rats in this group 
were treated with 0.6mg/kg bw of glibenclamide daily 
after the induction of diabetes. 
The glibenclamide and the extracts of Spondias 
mombin and Curcuma longa were administered daily 
using an oro-gastric cannula for 42 days. On day 43, 
blood was collected by direct cardiac puncture for 
determination of blood glucose concentration and 
glycosylated haemoglobin. 
 
Determination of blood glucose concentration and 
glycosylated haemoglobin: Blood glucose 
concentration was estimated using the method 
described by Das et al., (2012). During the course of 
the study, blood glucose concentration was determined 
thrice: firstly, prior to administration of alloxan to 
induce diabetes (Day 0); secondly, 72 hours after 
administration of alloxan (Day 3; to confirm diabetic 
rats subsequently used for the study); and thirdly, at 
the end of study (Day 46). Glycosylated haemoglobin 
was also determined at the end of study (Day 46) using 
the method described by Kovatchev et al., (2000). 
 
Statistical analysis: Results are as presented in Table 
1 and expressed as means ± standard error of means. 
Significant differences were determined using the one-
way ANOVA; differences between groups were 
determined using LSD Post Hoc test. A p value of less 
than 0.05 was considered statistically significant. 
 
RESULTS AND DISCUSSION 
Effect of methanolic extract of Spondias mombin 
leaves and Curcuma longa rhizomes on blood glucose: 
Table 1 shows the effect of methanolic extract of 
Spondias mombin leaves and Curcuma longa 
rhizomes on blood glucose concentration in male 
wistar rats. Compared to Group 2 (untreated diabetic) 
rats, administration of extracts of Spondias mombin 
significantly reduced blood glucose in a dose 
dependent manner amongst Group 3 and 4 rats (p< 
0.05). This effect of Spondias mombin is comparable 
to the effect of administration of glibenclamide 
observed amongst Group 9 rats. Although the post-
treatment blood glucose concentration following the 
administration of Spondias mombin at both doses were 
significantly higher than the post-treatment blood 
glucose concentration following the administration of 
glibenclamide; the percentage reduction (-33.33%) 
observed for Spondias mombin at a (high) dose of 
400mg/kg bw amongst Group 4 rats was marginally 
lower than that observed for glibenclamide (-29.13%) 
amongst Group 9 rats. Perhaps suggesting a greater 
potency of methanolic extract of Spondias mombin 
compared to glibenclamide. Furthermore, a 
comparison of the percentage reduction in blood 
glucose concentration at both low and high doses 
suggests that Spondias mombin is perhaps of 
marginally higher potency compared Curcuma longa; 
differences in blood glucose concentration was found 
to be significant (p<0.05). By comparison, Curcuma 
longa extract at both low and high doses also caused a 
significant and dose dependent reduction in the blood 
glucose concentration amongst Groups 5 and 6 rats 
respectively as compared to Group 2 (untreated 
diabetic) rats (p< 0.05). This effect of Curcuma longa 
is also comparable to the effect of administration of 
glibenclamide amongst Group 9 rats. However, the 
percentage reduction in blood glucose concentration 
caused by Curcuma longa at high dose (-28.36%) is 
marginally higher than that of glibenclamide (-
29.13%); furthermore, these differences in blood 
glucose concentration were observed to be significant 
(p<0.05). The combined administration of both 
extracts amongst Groups 7 and 8 rats, also caused a 
significant and dose dependent reduction in blood 
glucose concentration compared to both Group 2 
(untreated diabetic) and Group 9 (glibenclamide 
treated) rats (p< 0.05). Noteworthy, the reduction 
observed in blood glucose concentration following the 
combined administration of both extracts is greater 
than the reduction observed following the single 
administration of either extract: apparently suggesting 
either a possible additive or indeed a synergistic effect 
of both extracts on blood glucose concentration. 
 
Effect of methanolic extract of Spondias mombin 
leaves and Curcuma longa rhizomes on glycosylated 
haemoglobin: Table 1 also shows the effect of 
methanolic extract of Spondias mombin leaves and 
Curcuma longa rhizomes on glycosylated 
haemoglobin levels in male wistar rats. Compared to 
Group 2 (untreated diabetic) rats, administration of 
Spondias mombin extract significantly reduced 
glycosylated haemoglobin in a dose dependent manner 
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amongst Groups 3 and 4 rats (p< 0.05); this is similar 
to the effect of glibenclamide administration as seen 
amongst Group 9 rats (p< 0.05). Similarly, 
administration of Curcuma longa extract caused a 
significant and dose dependent reduction in 
glycosylated haemoglobin amongst Groups 5 and 6 
rats compared to Group 2 (untreated diabetic) rats (p< 
0.05). The combined administration of both extracts 
also caused a significant and dose dependent reduction 
in glycosylated haemoglobin amongst Groups 7 and 8 
rats compared Group 2 (untreated diabetic) rats (p< 
0.05). However, at low doses of both extracts, 
significant differences were not observed for 
glycosylated haemoglobin amongst Group 3 and 
Group 5 rats (p>0.05). 
 

















Group 1: Untreated non-diabetic 4.74 ± 0.06 4.79 ± 0.03 1.05 3.56 ± 0.01 
Group 2: Untreated diabetic 17.73 ± 0.05 23.50 ± 0.07b 32.54 9.17 ± 0.01b 
Group 3: Diabetic + low dose 
Spondias mombin 
19.47 ± 0.06 15.57 ± 0.04 ab -20.03 7.72 ± 0.21 ab 
Group 4: Diabetes + high dose 
Spondias mombin 
20.64 ± 0.03 13.76 ± 0.04 ab -33.33 5.16 ± 0.09 a 
Group 5: Diabetes + low dose 
Curcuma longa 
17.98 ± 0.07 14.64 ± 0.03 ab -18.58 7.82±0.01 ab 
Group 6: Diabetes + high dose 
Curcuma longa 
20.59 ± 0.05 14.75 ± 0.03 ab -28.36 5.34±0.01 a 
Group 7: Diabetes + combined 
low doses of Spondias mombin 
and Curcuma longa 
17.46 ± 0.01 10.92 ± 0.02 ab -37.46 4.83±0.02 a 
Group 8: Diabetes + combined 
high doses of Spondias mombin 
and Curcuma longa 
19.54 ± 0.02 5.74 ± 0.02 ab -70.62 3.94±0.007 ab 
Group 9: Diabetes + 
glibenclamide 
17.85 ± 0.06 12.65 ± 0.08 a -29.13 5.06±0.01 a 
a = significant difference compared to Group 2 (p<0.05); b= significant difference compared to Group 9 (p<0.05) 
 
The present study is essentially a comparative 
assessment of the anti-diabetic potentials of 
methanolic extracts of Spondias mombin leaves and 
Curcuma longa rhizomes in alloxan induced diabetes 
using male wistar rats as models. Despite differences 
in methods of extraction, the results of our study 
validate a recent report on the anti-diabetic effects of 
the aqueous extract of Curcuma longa rhizomes in 
alloxan induced diabetic rats (Olatunde et al., 2014). 
The significant reduction in blood glucose 
concentration due to administration of each extract 
clearly suggests that these extracts possess possible 
hypoglycaemic properties; indicating a potential 
beneficial effect in alloxan induced diabetes. 
Expectedly, the effects of both extracts are similar to 
that of glibenclamide a popular anti-diabetic agent. 
However, the precise mechanism of interaction of both 
extracts in the reduction of blood glucose in alloxan 
induced diabetes is presently unclear. Our results 
suggest that apparently, at low doses both extracts 
exhibit some additive effects; whereas a synergism is 
noticeable at higher doses. Comparatively, the blood 
glucose of rats administered Spondias mombin leaves 
was significantly lower than those administered 
Curcuma longa rhizomes at both doses; suggesting 
perhaps a greater hypoglycaemic effect of Spondias 
mombin compared to Curcuma longa.  
 
Phytochemical screening of both plants has shown the 
presence of several compounds including: 
triterpenoid, glycosides, flavonoids, tannins, curcumin 
and sterols compounds (Okwu, 2001; Reher et al., 
1991; Kako et al., 1997; Grundy et al., 1969; Lees et 
al., 1977). These compounds have been shown to play 
a contributory role in ameliorating complications 
associated with diabetes (Xi, 2007). The possible 
mechanism of action of these compounds in reducing 
blood glucose include: stimulation of insulin from 
residual beta cells; (Xi, 2007; Youn et al., 2004) 
enhancement of glucose transport to body tissues; 
(Youn et al., 2004; Okonkwo and Okoye, 2009) and 
inhibition of gastrointestinal absorption of glucose 
(Luka and Tijjani, 2013; Bajaj and Srinivasan, 1999; 
Pari et al., 2001). 
 
The results obtained following administration of both 
extracts shows a significant reduction in glycosylated 
haemoglobin. Compared with Group 2 (untreated 
diabetic) rats, all treatment groups exhibited a 
decrease in glycosylated haemoglobin suggesting that 
extracts of Spondias mombin leaves and Curcuma 
Comparative Assessment of Methanolic Extracts of Hog…..                                                                            1635 
SARONEE, F; BEKINBO, MT; OJEKA, SO; DAPPER, DV 
 
longa rhizomes could possibly ameliorate the long-
term consequences of hyperglycaemia. The 
glycosylated haemoglobin of rats administered low 
dose Spondias mombin leaves was however, not 
significantly different from those administered low 
dose Curcuma longa rhizomes. This finding suggest 
that no differences exist between Spondias mombin 
leaves and Curcuma longa rhizomes with respect to 
glycosylated haemoglobin values; this is at variance 
with the effect of both extract on blood glucose 
concentration described above. Perhaps observable 
differences in glycosylated haemoglobin values 
require a longer time frame to manifest in our 
experimental models. Notably, the effect of the 
combined administration of both extracts on 
glycosylated haemoglobin is greater than the effect of 
single administration of either extract. 
 
In conclusion, this study reports that methanolic 
extracts of Spondias mombin leaves and Curcuma 
longa rhizomes administered either singly or in 
combination caused a dose dependent reduction in 
blood glucose concentration and glycosylated 
haemoglobin in alloxan induced diabetes in male 
wistar rats. Apparently, Spondias mombin leaves 
possessed greater anti-diabetic properties compared to 
Curcuma longa rhizomes; the effects of the combined 
administration are greater than the single 
administration of either extract and comparable to 
glibenclamide effects.  
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